MLABMesa Laboratories, Inc.Healthcare · Medical - Equipment & Servicesas of 2026-09-16
Horizon

Issued 2026-09-16 at $125.29 · now $125.29 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, MLAB has typically landed between $100.19 and $152.04 — a range of −20.0% to +21.4% from the issuance price $125.29.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

5,003 overlapping 1 month windows · 2006-09-26 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($125.29) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where MLAB has typically landed a month from the 2026-09-16 close of $125.29 — the range is history, not a prediction.

$100.19worst · -20.0%$152.04best · +21.4%
  • now $125.29 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $123.28 (-1.6%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $112.16–$134.4
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $100.19–$152.04
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 5,003 windows spanning 2006-09-26 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2025-07-07−38.2%−38.2%+0.0%
2025-07-08−32.6%−37.6%+0.0%
2023-09-01−31.0%−31.0%+0.0%
3 best
2022-10-21+55.3%+0.0%+59.3%
2022-10-20+49.2%−0.9%+57.9%
2022-10-19+47.3%−4.8%+51.7%

5,003 overlapping windows · 2006-09-26 – 2026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~20 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
65%
+2.6%
n=20
Feb
50%
+1.1%
n=20
Mar
30%
−2.9%
n=20
Apr
60%
+3.3%
n=20
May
40%
−0.9%
n=20
Jun
50%
+2.5%
n=20
Jul
65%
+3.3%
n=20
Aug
40%
−0.7%
n=20
Sep
60%
−1.2%
n=20
Oct
70%
+2.1%
n=20
Nov
70%
+5.1%
n=20
Dec
55%
+2.4%
n=20

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$131$592026-08-13: 2 insider purchases, $902K — Kadia Siddhartha, Tripeny R Tony2026-08-13: 1 insider sale, $800K — Sullivan John James2026-06-22: 3 insider sales, $518K — Sakys John, Archbold Brian David, Crennen Lyndsey Elizabeth2026-06-16: 3 insider sales, $252K — Sakys John, Archbold Brian David, Crennen Lyndsey Elizabeth2026-03-10: 3 insider purchases, $452K — Ladiwala Shiraz Shabanali, Tripeny R Tony, Capone Mark Christopher2026-03: 3 open-market purchases, $452K2026-06: 6 open-market sales, $770K2026-08: 2 open-market purchases, $902K2026-08: 1 open-market sale, $800K↑ buys↓ salesofficer Kadia Siddhartha — Purchase on 2026-08-13, filed 4 days after the tradedirector Sullivan John James — Sale on 2026-08-13, filed 4 days after the tradedirector Tripeny R Tony — Purchase on 2026-08-13, filed 4 days after the tradeofficer Sakys John — Sale on 2026-06-22, filed 1 day after the tradeofficer Archbold Brian David — Sale on 2026-06-22, filed 1 day after the tradeofficer Crennen Lyndsey Elizabeth — Sale on 2026-06-22, filed 1 day after the tradeofficer Sakys John — Sale on 2026-06-16, filed 1 day after the tradeofficer Archbold Brian David — Sale on 2026-06-16, filed 1 day after the tradeofficer Crennen Lyndsey Elizabeth — Sale on 2026-06-16, filed 1 day after the tradedirector Ladiwala Shiraz Shabanali — Purchase on 2026-03-10, filed same daydirector Tripeny R Tony — Purchase on 2026-03-10, filed same daydirector Capone Mark Christopher — Purchase on 2026-03-10, filed same day
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-08-13Kadia SiddharthaofficerPurchase7,093 @ $112.80$800Kownership Δ n/a+9.5%not yet — horizon still open7,093Form 4 · filed 4 days after the trade
2026-08-13Sullivan John JamesdirectorSale7,093 @ $112.80$800K−28.5% of holding+9.5%not yet — horizon still open17,834Form 4 · filed 4 days after the trade
2026-08-13Tripeny R TonydirectorPurchase900 @ $113.69$102K+16.7% of holding+9.5%not yet — horizon still open6,298Form 4 · filed 4 days after the trade
2026-06-22Sakys JohnofficerSale2,827 @ $89.50$253K−12.5% of holding+5.3%not yet — horizon still open19,785Form 4 · filed 1 day after the trade
2026-06-22Archbold Brian DavidofficerSale2,516 @ $89.50$225K−28.3% of holding+5.3%not yet — horizon still open6,377Form 4 · filed 1 day after the trade
2026-06-22Crennen Lyndsey ElizabethofficerSale442 @ $89.50$40K−18.0% of holding+5.3%not yet — horizon still open2,020Form 4 · filed 1 day after the trade
2026-06-16Sakys JohnofficerSale1,223 @ $101.27$124K−6.9% of holding−1.1%not yet — horizon still open16,538Form 4 · filed 1 day after the trade
2026-06-16Archbold Brian DavidofficerSale1,151 @ $101.27$117K−23.7% of holding−1.1%not yet — horizon still open3,710Form 4 · filed 1 day after the trade
2026-06-16Crennen Lyndsey ElizabethofficerSale118 @ $101.27$12K−7.4% of holding−1.1%not yet — horizon still open1,473Form 4 · filed 1 day after the trade
2026-03-10Ladiwala Shiraz ShabanalidirectorPurchase3,500 @ $72.23$253K+69.7% of holding+26.1%+56.3%8,523Form 4 · filed same day
2026-03-10Tripeny R TonydirectorPurchase1,315 @ $76.00$100K+32.2% of holding+26.1%+56.3%5,398Form 4 · filed same day
2026-03-10Capone Mark ChristopherdirectorPurchase1,301 @ $76.35$99K+61.1% of holding+26.1%+56.3%3,429Form 4 · filed same day
2025-06-16Owens Gary MofficerSale1,939 @ $97.12$188K−4.1% of holding−26.3%−32.2%45,824Form 4 · filed 2 days after the trade
2025-06-16Sakys JohnofficerSale642 @ $97.12$62K−4.8% of holding−26.3%−32.2%12,865Form 4 · filed 2 days after the trade
2025-06-16Archbold Brian DavidofficerSale472 @ $97.12$46K−45.8% of holding−26.3%−32.2%558Form 4 · filed 2 days after the trade
2025-03-19Owens Gary MofficerSale21,000 @ $123.91$2.6M−32.6% of holding−2.9%−61.6%43,337Form 4 · filed 5 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

100 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-09-09Tripeny R TonydirectorAward / grant1,7741,774Form 4
2026-09-09Capone Mark ChristopherdirectorAward / grant2,4232,423Form 4
2026-09-09Hall ShannondirectorAward / grant1,7741,774Form 4
2026-09-09Sullivan John JamesdirectorAward / grant1,7741,774Form 4
2026-09-09Ladiwala Shiraz ShabanalidirectorAward / grant2,5102,510Form 4
2026-08-15Ladiwala Shiraz ShabanalidirectorOption exercise3,8100Form 4
2026-08-15Ladiwala Shiraz ShabanalidirectorOption exercise3,81012,333Form 4
2026-08-15Hall ShannondirectorOption exercise2,7840Form 4
2026-08-15Hall ShannondirectorOption exercise2,7846,973Form 4
2026-08-15Tripeny R TonydirectorOption exercise2,7840Form 4
2026-08-15Tripeny R TonydirectorOption exercise2,7849,082Form 4
2026-08-15Sullivan John JamesdirectorOption exercise2,7840Form 4
2026-08-15Sullivan John JamesdirectorOption exercise2,78420,618Form 4
2026-08-15Alltoft Jennifer SadiedirectorOption exercise2,7847,662Form 4
2026-08-15Alltoft Jennifer SadiedirectorOption exercise2,7840Form 4
2026-08-15Capone Mark ChristopherdirectorOption exercise2,7846,213Form 4
2026-08-15Capone Mark ChristopherdirectorOption exercise2,7840Form 4
2026-06-18Sakys JohnofficerOption exercise2,75620,330Form 4
2026-06-18Archbold Brian DavidofficerOption exercise2,4807,034Form 4
2026-06-18Sakys JohnofficerAward / grant2,28222,612Form 4
2026-06-18Archbold Brian DavidofficerAward / grant1,8598,893Form 4
2026-06-18Sakys JohnofficerOption exercise1,03617,574Form 4
2026-06-18Archbold Brian DavidofficerOption exercise8444,554Form 4
2026-06-18Crennen Lyndsey ElizabethofficerOption exercise3682,199Form 4
2026-06-18Crennen Lyndsey ElizabethofficerAward / grant2632,462Form 4
2026-06-18Crennen Lyndsey ElizabethofficerOption exercise2331,831Form 4
2026-06-18Crennen Lyndsey ElizabethofficerOption exercise1251,598Form 4
2026-06-18Crennen Lyndsey ElizabethofficerOption exercise1250Form 4
2026-06-18Crennen Lyndsey ElizabethofficerOption exercise368367Form 4
2026-06-18Sakys JohnofficerOption exercise2,7562,755Form 4
2026-06-18Sakys JohnofficerOption exercise1,0360Form 4
2026-06-18Archbold Brian DavidofficerOption exercise8440Form 4
2026-06-18Archbold Brian DavidofficerOption exercise2,4802,480Form 4
2026-06-18Crennen Lyndsey ElizabethofficerOption exercise233232Form 4
2026-06-15Sakys JohnofficerOption exercise2,71717,761Form 4
2026-06-15Archbold Brian DavidofficerOption exercise2,4544,861Form 4
2026-06-15Archbold Brian DavidofficerCode E1,78011,852Form 4
2026-06-15Sakys JohnofficerAward / grant8,4168,416Form 4
2026-06-15Sakys JohnofficerOption exercise2,7175,416Form 4
2026-06-15Sakys JohnofficerCode E3,95115,755Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.